by Brooke E. Nichols, Betsy Wonderly Trainor, Grace Hampson, Yonatan H. Grad, Jeffrey D. Klausner
BackgroundRising antimicrobial resistance in Neisseria gonorrhoeae threatens the effectiveness of existing therapies. Ceftriaxone is the only recommended first-line (empiric) treatment for uncomplicated gonorrhea in the United States. Ciprofloxacin is no longer rec...